Summary
67 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: ¥28.7B against ¥28.6B.
- The share price is below the Bulios Fair Price.
- Out of every 100 JPY of revenue, 7.7 JPY is left as net profit.
What to watch
- Revenue fell by 11% a year over the last 3 years.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 8.1 JPY for 1 JPY of yearly profit. Over the last five years it was 7.6 JPY on average.
Valuation in detailIs it growing?
SlowlyRevenue (JPY)
Diluted EPS (JPY)
- Analyst estimate
Revenue fell by 8.3% a year over 5 years. Over the last 3 years it fell by 11% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 JPY of revenue goes
- Cost of sales 72 JPY
- Research and development 3.9 JPY
- Sales and administration 15 JPY
- Taxes and other 0.6 JPY
- Net profit 7.7 JPY
Net profit, industry median (Chemicals - Specialty) 5.9 JPY
Out of every 100 JPY of revenue, 7.7 JPY is left as net profit.
Profitability in detailIs it financially healthy?
YesIt holds more cash than debt.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 4.51%
- Paid out of profit
- 37%
You receive $1.08 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.